Extrapolating from the ADRIATIC trial.
New comment by Radiation Oncologist at Quillen VA Medical Center ( March 13, 2025)
The longer we follow SBRT patients, there will be relapses and recurrences. The immune modulators make sense, so that makes randomized trial +/- placebo-controlled. I would no...